No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Extended letrozole therapy improves disease-free survival in postmenopausal patients with breast cancer

byTeddy Guo

October 6, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Quadruple combination pill for hypertension is more effective at lowering blood pressure than standard dose monotherapy

RelatedReports

StudyGraphics

#VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

June 17, 2025

One-year of Herceptin preferable to two-year regimen

Oncology

Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

April 11, 2025

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Chronic Disease

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

April 2, 2025

StudyGraphics

#VisualAbstract Lack of sentinel-lymph node biopsy does not alter survival in early invasive breast cancer

March 27, 2025

Pediatric chronic pain patients typically Caucasian, female adolescents.

Prophylactic scopolamine butylbromide reduces death rattle at end of life compared to placebo

Influenza vaccine not associated with increased risk of epilepsy in children

Vaccine-induced immune thrombotic thrombocytopenia may worsen the severity of cerebral venous thrombosis

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Methylprednisolone in severe COVID-19 pneumonia associated with clinical benefit in those with high baseline serum ferritin

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports